| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | DXCM | Common Stock | Sale | -$248K | -578 | -3.53% | $428.51 | 15.8K | Jul 6, 2021 | by Trust | F1, F2, F3 |
| transaction | DXCM | Common Stock | Sale | -$172K | -400 | -2.53% | $429.33 | 15.4K | Jul 6, 2021 | by Trust | F1, F3, F4 |
| transaction | DXCM | Common Stock | Sale | -$736K | -1.71K | -11.1% | $430.56 | 13.7K | Jul 6, 2021 | by Trust | F1, F3, F5 |
| transaction | DXCM | Common Stock | Sale | -$124K | -286 | -2.09% | $432.05 | 13.4K | Jul 6, 2021 | by Trust | F1, F3, F6 |
| holding | DXCM | Common Stock | 16.5K | Jul 6, 2021 | Direct |
| Id | Content |
|---|---|
| F1 | On March 5, 2021, Mr. Balo adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Balo. The shares set forth above were sold pursuant to the 10b5-1 Plan. |
| F2 | This transaction was executed in multiple trades at prices ranging from $428.125 to $429.060. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. |
| F3 | Shares are held by the Balo Family Trust U/A/D 4/6/2006, with respect to which the reporting person is a trustee. |
| F4 | This transaction was executed in multiple trades at prices ranging from $429.141 to $429.401. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected. |
| F5 | This transaction was executed in multiple trades at prices ranging from $430.270 to $430.919. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected. |
| F6 | This transaction was executed in multiple trades at prices ranging from $431.455 to $432.050. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected. |
*EVP Regulatory Strategy Clinical Affairs and Strategic Partnership Development